COPPSERS
ALXN

Commonwealth of Pennsylvania Public School Employees Retirement System’s Alexion Pharmaceuticals ALXN Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27,691
Closed -$5.09M – 1859
2021
Q2 		$5.09M Buy
27,691
+195
+0.7% +$33.5K 0.06% 292
2021
Q1 		$4.2M Buy
27,496
+151
+0.6% +$23.4K 0.05% 326
2020
Q4 		$4.27M Buy
27,345
+7,038
+35% +$904K 0.06% 286
2020
Q3 		$2.32M Buy
20,307
+7,680
+61% +$829K 0.05% 390
2020
Q2 		$1.42M Sell
12,627
-1,511
-11% -$160K 0.03% 404
2020
Q1 		$1.27M Sell
14,138
-112
-0.8% -$11K 0.03% 404
2019
Q4 		$1.54M Sell
14,250
-118
-0.8% -$12.6K 0.03% 373
2019
Q3 		$1.41M Buy
14,368
+4,408
+44% +$497K 0.03% 382
2019
Q2 		$1.3M Sell
9,960
-3,105
-24% -$400K 0.02% 397
2019
Q1 		$1.77M Buy
13,065
+894
+7% +$111K 0.03% 300
2018
Q4 		$1.19M Sell
12,171
-6,117
-33% -$723K 0.02% 378
2018
Q3 		$2.54M Sell
18,288
-5,004
-21% -$628K 0.04% 308
2018
Q2 		$2.89M Buy
23,292
+3,456
+17% +$404K 0.04% 326
2018
Q1 		$2.21M Sell
19,836
-148
-0.7% -$17.7K 0.03% 393
2017
Q4 		$2.39M Buy
19,984
+1,833
+10% +$223K 0.03% 344
2017
Q3 		$2.55M Buy
18,151
+1,468
+9% +$199K 0.04% 323
2017
Q2 		$2.03M Buy
16,683
+21
+0.1% +$2.44K 0.03% 353
2017
Q1 		$2.02M Buy
16,662
+3,807
+30% +$491K 0.03% 342
2016
Q4 		$1.57M Buy
12,855
+47
+0.4% +$5.75K 0.03% 353
2016
Q3 		$1.57M Sell
12,808
-5,129
-29% -$660K 0.03% 352
2016
Q2 		$2.09M Buy
17,937
+1,219
+7% +$173K 0.04% 332
2016
Q1 		$2.33M Buy
16,718
+1,996
+14% +$293K 0.05% 281
2015
Q4 		$2.81M Buy
14,722
+192
+1% +$33.5K 0.06% 243
2015
Q3 		$2.27M Sell
14,530
-10,612
-42% -$1.94M 0.05% 275
2015
Q2 		$4.54M Buy
25,142
+1,951
+8% +$337K 0.08% 231
2015
Q1 		$4.02M Sell
23,191
-12,989
-36% -$2.35M 0.07% 247
2014
Q4 		$6.69M Sell
36,180
-99
-0.3% -$18.3K 0.1% 227
2014
Q3 		$6.02M Buy
36,279
+52
+0.1% +$8.54K 0.09% 242
2014
Q2 		$5.66M Sell
36,227
-1,675
-4% -$264K 0.08% 258
2014
Q1 		$5.77M Buy
37,902
+478
+1% +$76K 0.09% 255
2013
Q4 		$4.97M Sell
37,424
-13,615
-27% -$1.63M 0.08% 282
2013
Q3 		$5.93M Buy
51,039
+11,303
+28% +$1.24M 0.1% 248
2013
Q2 		$3.67M Buy
+39,736
New +$3.83M 0.06% 327

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's ALXN Position: Q3 2021 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 27,691 shares — an estimated $5.09M sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $6.69M in Q4 2014. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 27,691 Alexion Pharmaceuticals shares in Q3 2021, an estimated $5.09M.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's Alexion Pharmaceuticals position peaked at $6.69M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q3 2021, filed 10 Nov 2021.